SubHero Banner

3rd Quarter 2017

Key topics in this quarter’s edition include:

  • Ataluren: for protein restoration therapy for the treatment of nonsense mutation Duchenne muscular dystrophy
  • Copanlisib: treatment of relapsed or refractory follicular lymphoma in patients who have received at least 2 prior therapies
  • Semaglutide: as an adjunct to diet and exercise for the treatment of type 2 diabetes mellitus

Download PDF